Find your next paid study

Hansoh BioMedical R&D CompanyNCT06892379

~$150 – $4,500

Actual pay is set by the research site.

Prospective Case Series Evaluating 6-Month and 12-Month Outcomes After Cryoneurolysis for Chronic Pain

To prospectively describe patient-centered and health utilization outcomes through 12 months after cryoneurolysis performed as routine clinical care for chroni…

Chronic PainPERIPHERAL NEUROPATHYOccipital Neuralgia+11 more

Yale UniversityNCT07639060

Actual pay is set by the research site.

Changes in Motor Function, Quality of Life, Cardiorespiratory Fitness, and Physiological Markers in People With Parkinson's Disease Following Different Exercise Interventions.

Parkinson's disease (PD) is a progressive neurological condition that can affect movement, balance, endurance, and overall quality of life. Exercise is widely …

Parkinson Disease (PD)

University of Texas, El PasoNCT07221266

Actual pay is set by the research site.

Diabetes MellitusFoot Ulcer

Improving Diabetic Foot Ulcer Offloading: A Pilot Study on the Impact of Removable Cast Walker Design Factors on Usability

Within their lifetime, over 30% of people living with diabetes will develop a diabetic foot ulcer (DFU), many of which will never heal and may require amputati…

Rosalind Franklin University of Medicine and ScienceNCT05415878

Actual pay is set by the research site.

Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma

Histological transformation in Splenic Marginal Zone Lymphoma (t-SMZL) represents an unmet clinical and biological need, invariably associated with poor progno…

Transformed Splenic Marginal Zone Lymphoma

International Extranodal Lymphoma Study Group (IELSG)NCT06712459

~$10 – $1,125

Actual pay is set by the research site.

PRIDE III Prison Interventions and HIV Prevention Collaboration

The primary objective of this research project is to identify barriers to scale-up of Opioid Agonist Therapy (OAT) in the justice systems (prisons and probatio…

HivOpioid Use

Yale UniversityNCT06962033

Actual pay is set by the research site.

Sequential Left Ventricular Assist Device (LVAD) Unloading and Conditioning to Induce Sustained Cardiac Recovery

The purpose of this study is to investigate the potential recovery of heart function in end-stage heart failure patients supported with a Left Ventricular Assi…

Heart Failure

STAVROS G DRAKOSNCT03238690

~$10 – $1,125

Actual pay is set by the research site.

A Randomized, Sham Controlled, Masked Phase II Study to Evaluate the Neuroprotective Effect of Hyperbaric Oxygen Therapy on Optic Neuropathy

The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.

Optic NeuropathyGlaucoma

Stanford UniversityNCT06128720

Actual pay is set by the research site.

Evaluating Real-World Spine Outcomes for Spinal and Orthobiologics Products From Around the World

A global, prospective, non-randomized, multicenter, observational, post-market, medical record review registry evaluating real-world evidence for SeaSpine prod…

Spinal Disease

SeaSpine, Inc.NCT04364295

~$10 – $1,050

Actual pay is set by the research site.

ICH - Intracerebral HemorrhageIVH- Intraventricular HemorrhageTBI Traumatic Brain Injury

Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization: A Randomized Controlled Clinical Trial (PEARL)

The goal of this clinical trial is to assess if EVD placement using augmented reality is non inferior to image-guidance systems for assistance in adult patient…

The Cooper Health SystemNCT07042048

Actual pay is set by the research site.

Phase 1

Phase I Study of Gilteritinib for ALK Positive Non-Small Cell Lung Cancer

This phase I trial is studying the safety, side effects, and best dose of gilteritinib in treating patients with stage IV ALK positive non-small cell lung canc…

Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8

University of Michigan Rogel Cancer CenterNCT06225427

~$150 – $3,000

Actual pay is set by the research site.

Phase 2

A 26-Week (With 26 Week Extension) Randomized, Multi-Center, Double-Blind Phase 2 Study to Evaluate the Efficacy and Safety of XC001 Gene Therapy as an Adjunct to Coronary Artery Bypass Graft Surgery for Patients With Symptomatic Coronary Artery Disease With Left Ventricular Dysfunction at Risk for Incomplete Revascularization

This is a 26-week (with a 26-week extension) multicenter, randomized, double-blind, placebo-controlled Phase 2 study of XC001 versus placebo. Approximately 116…

Coronary Artery Disease (CAD)